Pérez-Lamas, Lucía; Luna, Alejandro; Boque, Concepción; Xicoy, Blanca; Giraldo, Pilar; Pérez-López, Raúl; Ruiz-Nuno, Concepción; de-las-Heras, Natalia; Mora-Castera, Elvira; López-Marin, Javier; Segura-Díaz, Adrián; Gómez, Valle; Vélez-Tenza, Patricia; Sierra-Pacho, Magdalena; Vera-Goni, Juan-Antonio; Moreno-Vega, Melania; Álvarez-Larrán, Alberto; Cortés, Montse; Pérez-Encinas, Manuel-Mateo; Carrascosa-Mastell, Patricia; Angona, Anna; Rosell, Ana; Lakhwani, Sunil; Colorado, Mercedes; Ramila, Elena; Cervero, Carlos; Cuevas, Beatriz; Villalón-Blanco, Lucía; de-Paz, Raquel; Paz-Coll, Antonio; Fernández, María-José; Felipe-Casado, Luis; Alonso-Domínguez, Juan-Manuel; Anguita-Arance, María-Magdalena; Salamanca-Cuenca, Araceli; Jiménez-Velasco, Antonio; Osorio-Prendes, Santiago; Santaliestra, Marta; Lis-Chulvi, María-José; Hernández-Boluda, Juan-Carlos; García-Gutiérrez, Valentín
(MDPI, 2023-02)
(1) Background: Despite the prognostic improvements achieved with tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML), a minority of patients still fail TKIs. The recent introduction of asciminib may be a ...